Immunome

Immunome is a biotechnology company focused on leveraging the human immune system to change the paradigm of cancer treatment. Immunome’s growing pipeline of cancer immunotherapies, targeting novel areas of cancer biology, is fueled by a proprietary, outcome-based discovery engine that was originally developed at Massachusetts Institute of Technology’s Whitehead Institute. Our technology both captures and deeply interrogates patient immune responses to uncover novel tumor antigens and fully human antibodies with therapeutic potential against those targets. For more information about the company, visit http://immunome.com.

Executives

Exton-based Immunome Appoints Purnanand Sarma, PhD, as President and Chief Executive Officer

EXTON, PA — Immunome, a biotechnology company focused on discovering first-in-class therapeutics by leveraging the most highly educated components of the human immune system from cancer patients, announced recently that …